Annual Closing 2025
Eurogentec will be closed from Wednesday the 25th of December 2025 until Friday the 2nd of January 2026.
Company
Kaneka Eurogentec completes commercial mRNA GMP facility expansion
Newly accredited GMP facility for commercial manufacturing of mRNA in anticipation of customer BLA submission.
New Benchmark: 1 kg of Plasmid DNA Manufactured
Kaneka Eurogentec sets new benchmark in plasmid DNA manufacturing with the production of 1 kg of plasmid DNA
GMP Compliance Verification
PSC Biotech inspection results: AnaSpec, our US subsidiary, meets the requirements to produce Active Pharmaceutical Ingredients (Drug Substance) a...
Open Day : over 300 visitors explored our facilities!
Last weekend, we had the pleasure of hosting hundreds of visitors during the Discovery Days: Chemistry and Life Sciences event, organized with Esse...
Our brand-new labs are now fully operational
After a year of revamping, we are thrilled to announce that our new Process Transfer & Development labs are ready for your projects!
We welcomed the Ambassador of Japan to Belgium at Kaneka Eurogentec
Eurogentec welcomed the Ambassador of Japan to Belgium to visit our new GMP production facilities and learn more about our COVID-19 current activit...
His Majesty King Philippe gave us the honor to visit Kaneka Eurogentec
This visit represents a great acknowledgement of our expertise in the fight against COVID-19.
Kaneka Eurogentec receives GMP accreditation for new mRNA manufacturing facility – COVID-19 vaccine production ongoing
Kaneka Eurogentec, a custom service and FDA inspected Contract Development and Manufacturing Organization (CDMO) received GMP accreditation by the ...